As Patrick F. Fogarty, MD, briefly discusses the improvements in the length of time of which new factor 8 and factor 9 protein products extend treatment for hemophilia patients and stresses why it is important for clinicians to work together to ensure that their patients have access to these longer-acting agents, the panelists consider issues that should be addressed by managed care professionals and clinicians.
From an economic standpoint, Hugh Fatodu, RPh, MBA, explains that longer-acting agents lead to more product waste and states that a large amount of unused product sits inside the patient’s home. However, he believes that specialty pharmacies can help improve the amount of inventory that is provided to patients.
Maria Lopes, MD, MS, and Mr Fatodu explain that to improve the amount of protein product administered to the patient and to reduce the amount of product waste, it is key to determine how much of the drug is necessary to the patient and develop a fair balance plan.
Dr Lopes and Mr Fatodu explain that the end result of practicing fair balance should minimize waste by recommending lower dosage requirements, yet should ensure that patients do not have bleeding episodes.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Data analysis showed that 40% of patients who filled a prescription for Wegovy in 2021 or 2022 were still taking it a year later; both Democrats and reproductive rights organizations are pressuring the Biden administration to ensure health insurers fully cover contraception; CMS implemented Medicare changes in March that limited access to blood tests that help transplant recipients ensure their organs remain healthy.
Read More